Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Abridge: The company raised $250 million of Series D venture funding in a deal led by IVP and Elad Gil on February 19, 2005, putting the company’s pre-money valuation at $2.5...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Abcuro: The company raised $200 million of Series C venture funding in a deal led by New Enterprise Associates on February 12, 2025, putting the company’s pre-money valuation...
Strategy | Financing | Macro & Markets Private Placement / Financing Transactions Carlsmed: The company raised $64.5 million of Series C venture funding in a deal led by U.S. Venture Partners and B Capital Group on February 6, 2025. The Vertical Group also...
Strategy | Financing Transactions Private Placement / Financing Transactions Atalanta Therapeutics: The company raised $170 million of Series B venture funding in a deal led by Sanofi Ventures and EQT Life Sciences on January 28, 2025. Novartis, RiverVest Venture...
Strategy | Financing Transactions Private Placement / Financing Transactions Tune Therapeutics: The company raised $182.4 million of Series B venture funding in a deal led by Hevolution Foundation, Regeneron Ventures and Yosemite on January 23, 2025, putting the...
Strategy | Financing Transactions Private Placement / Financing Transactions Truveta: The company raised $320 million of Series C venture funding from Illumina and Regeneron Pharmaceuticals on January 13, 2025, putting the company’s pre-money valuation at $1.2...
